{"id":"https://openalex.org/W2954373019","doi":"https://doi.org/10.1016/j.ijpharm.2019.118490","title":"A simple blending with \u03b1-glycosylated naringin produces enhanced solubility and absorption of pranlukast hemihydrate","display_name":"A simple blending with \u03b1-glycosylated naringin produces enhanced solubility and absorption of pranlukast hemihydrate","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2954373019","doi":"https://doi.org/10.1016/j.ijpharm.2019.118490","mag":"2954373019","pmid":"https://pubmed.ncbi.nlm.nih.gov/31271814"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2019.118490","doi":"https://doi.org/10.1016/j.ijpharm.2019.118490","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2019.118490","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005990134","display_name":"Hiromasa Uchiyama","orcid":"https://orcid.org/0000-0003-4752-6846","observed_orcids":["https://orcid.org/0000-0003-4752-6846"]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromasa Uchiyama","raw_affiliation_strings":["Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052577338","display_name":"Kazunori Kadota","orcid":"https://orcid.org/0000-0002-3370-6662","observed_orcids":["https://orcid.org/0000-0002-3370-6662"]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazunori Kadota","raw_affiliation_strings":["Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan"],"raw_orcid":"https://orcid.org/0000-0002-3370-6662","affiliations":[{"raw_affiliation_string":"Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050853117","display_name":"Akihito Nakanishi","orcid":"https://orcid.org/0000-0002-4850-6321","observed_orcids":["https://orcid.org/0000-0002-4850-6321"]},"institutions":[{"id":"https://openalex.org/I4405276261","display_name":"TOYO Sugar Refining Co., Ltd. (Japan)","ror":"https://ror.org/053hbky12","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405276261"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihito Nakanishi","raw_affiliation_strings":["Toyo Sugar Refining Co., Ltd., 18-20 Koami-Cho, Nihonbashi, Chuo-ku, Tokyo 103-0016, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toyo Sugar Refining Co., Ltd., 18-20 Koami-Cho, Nihonbashi, Chuo-ku, Tokyo 103-0016, Japan","institution_ids":["https://openalex.org/I4405276261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082741800","display_name":"Mahamadou Tandia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405276261","display_name":"TOYO Sugar Refining Co., Ltd. (Japan)","ror":"https://ror.org/053hbky12","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405276261"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mahamadou Tandia","raw_affiliation_strings":["Toyo Sugar Refining Co., Ltd., 18-20 Koami-Cho, Nihonbashi, Chuo-ku, Tokyo 103-0016, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toyo Sugar Refining Co., Ltd., 18-20 Koami-Cho, Nihonbashi, Chuo-ku, Tokyo 103-0016, Japan","institution_ids":["https://openalex.org/I4405276261"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080893014","display_name":"Yuichi Tozuka","orcid":"https://orcid.org/0000-0002-4091-4451","observed_orcids":["https://orcid.org/0000-0002-4091-4451"]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yuichi Tozuka","raw_affiliation_strings":["Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. Electronic address: ytozuka@gly.oups.ac.jp","Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan"],"raw_orcid":"https://orcid.org/0000-0002-4091-4451","affiliations":[{"raw_affiliation_string":"Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. Electronic address: ytozuka@gly.oups.ac.jp","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan","institution_ids":["https://openalex.org/I90237989"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5080893014"],"corresponding_institution_ids":["https://openalex.org/I90237989"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.552,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.55620762,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"567","issue":null,"first_page":"118490","last_page":"118490"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solubilizers","display_name":"solubilizing agents","score":0.8140000104904175},{"id":"https://openalex.org/keywords/drug-solubility-enhancement","display_name":"drug solubility enhancement","score":0.8149999976158142},{"id":"https://openalex.org/keywords/oral-absorption","display_name":"oral absorption","score":0.6299999952316284},{"id":"https://openalex.org/keywords/physical-mixtures","display_name":"physical mixtures","score":0.5460000038146973},{"id":"https://openalex.org/keywords/low-water-solubility","display_name":"low water solubility","score":0.6549999713897705},{"id":"https://openalex.org/keywords/surface-tension","display_name":"surface tension","score":0.550000011920929},{"id":"https://openalex.org/keywords/sodium-dodecyl-sulfate","display_name":"sodium dodecyl sulfate","score":0.8840000033378601},{"id":"https://openalex.org/keywords/caco-2-cell-viability","display_name":"Caco-2 cell viability","score":0.8180000185966492},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.4970000088214874},{"id":"https://openalex.org/keywords/flavonoid-glycosides","display_name":"flavonoid glycosides","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2777335409","wikidata":"https://www.wikidata.org/wiki/Q418469","display_name":"Naringin","level":2,"score":0.9921430349349976},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8038634061813354},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.714066207408905},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6201921701431274},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.4857836067676544},{"id":"https://openalex.org/C2775963812","wikidata":"https://www.wikidata.org/wiki/Q407857","display_name":"Rutin","level":3,"score":0.4768035113811493},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2707277536392212},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2521877884864807},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.1032266616821289},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002867","descriptor_name":"Chromones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002867","descriptor_name":"Chromones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002867","descriptor_name":"Chromones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006031","descriptor_name":"Glycosylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044950","descriptor_name":"Flavanones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D044950","descriptor_name":"Flavanones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D044950","descriptor_name":"Flavanones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ijpharm.2019.118490","doi":"https://doi.org/10.1016/j.ijpharm.2019.118490","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2019.118490","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:31271814","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31271814","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"},{"id":"mag:3205617648","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902255319429935","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8023426868","display_name":"Hybrid formulations of the organic nanocomposite via structural investigations","funder_award_id":"18K06614","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320320212","display_name":"Japan Society for the Promotion of Science London","ror":"https://ror.org/02m7axw05"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1499768710","https://openalex.org/W1974376054","https://openalex.org/W1991916654","https://openalex.org/W2003566226","https://openalex.org/W2011249217","https://openalex.org/W2027792870","https://openalex.org/W2032183185","https://openalex.org/W2044380869","https://openalex.org/W2044388178","https://openalex.org/W2047161363","https://openalex.org/W2053085437","https://openalex.org/W2060139782","https://openalex.org/W2070189856","https://openalex.org/W2070332894","https://openalex.org/W2076006077","https://openalex.org/W2082738383","https://openalex.org/W2093807649","https://openalex.org/W2121573834","https://openalex.org/W2129039800","https://openalex.org/W2753084517","https://openalex.org/W2767999118","https://openalex.org/W2768738643","https://openalex.org/W2791791543"],"related_works":["https://openalex.org/W4396888407","https://openalex.org/W1931194559","https://openalex.org/W2089276543","https://openalex.org/W4380081091","https://openalex.org/W2767566034","https://openalex.org/W4283585137","https://openalex.org/W3215753499","https://openalex.org/W4400166867","https://openalex.org/W2776159526","https://openalex.org/W4296968064"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-07-12T00:00:00"}